This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

ADELE E. SHEPLAR, M.D.; MARTHA JANE SPENCE, M.A.; WARD J. MacNEAL, M.D.

Arch Surg. 1934;29(5):858-865.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

EARLY INVESTIGATIONS OF STREPTOCOCOUS SERUM

The serum of animals immunized against hemolytic streptococci was early introduced for the treatment of human disease. Marmorek¹ employed a streptococcus of high virulence to immunize horses, asses and sheep. The serum of these animals was then found to possess preventive and curative value in the streptococcic infection of rabbits. Marmorek treated forty-six patients with severe erysipelas by the injection of from 5 to 20 cc. of serum, and all but one made a rapid recovery. He believed that a potent serum could be obtained only by employing for immunization a virulent and toxic strain of the streptococcus.

Subsequent clinical experience with serum therapy in streptococcic infections has resulted in conflicting opinions. Some reports were favorable, but perhaps more were unfavorable. In part, these discrepancies may be ascribed to the use of different serums, but this explanation is not quite adequate. Even today we . . . [Full Text PDF of this Article]

Author Affiliations
NEW YORK

From the Department of Pathology and Bacteriology, New York Post-Graduate Medical School and Hospital, Columbia University.

Footnotes
This work has been made possible by a grant from the Josiah Macy Jr. Foundation.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?